ID   4B9 [Human LCL mAb producing]
AC   CVCL_JA37
SY   HLCL 4B9
DR   ATCC; CRL-9008
DR   CCRID; 4201PAT-CCTCC00009
DR   Wikidata; Q54603353
RX   Patent=US4970070;
RX   Patent=US5837541;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9008.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Group B streptococci.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 11
//
RX   Patent=US4970070;
RA   Raff H.V.;
RT   "Protective monoclonal antibody compositions for infections due to
RT   group B Streptococcus.";
RL   Patent number US4970070, 13-Nov-1990.
//
RX   Patent=US5837541;
RA   Raff H.V.;
RT   "Cross-protective human monoclonal antibody compositions.";
RL   Patent number US5837541, 17-Nov-1998.
//